Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality.
作者信息
Glassock Richard J, Rule Andrew D
机构信息
Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Mayo Clinic, Rochester, MN, USA.
出版信息
Nephrol Dial Transplant. 2017 Apr 1;32(4):585-587. doi: 10.1093/ndt/gfx007.
Abstract
摘要
相似文献
1
Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality.用肾功能标志物对死亡率进行最佳预测与最佳确定肾功能如何预测死亡率并不相同。
Nephrol Dial Transplant. 2017 Apr 1;32(4):585-587. doi: 10.1093/ndt/gfx007.
2
Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.多种滤过标志物的变化与随后的心血管疾病风险及死亡率
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):941-8. doi: 10.2215/CJN.10101014. Epub 2015 Mar 30.
3
Hypothyroidism and renal function in patients with systolic heart failure.收缩性心力衰竭患者的甲状腺功能减退与肾功能
Tex Heart Inst J. 2010;37(1):66-9.
4
Rate of kidney function decline associates with increased risk of death.肾功能下降速度与死亡风险增加相关。
J Am Soc Nephrol. 2010 Nov;21(11):1814-6. doi: 10.1681/ASN.2010090954. Epub 2010 Oct 14.
5
Nephropathy: New aspects of mechanisms, diagnosis and therapy.肾病：发病机制、诊断及治疗的新进展
Acta Physiol (Oxf). 2018 Sep;224(1):e13162. doi: 10.1111/apha.13162. Epub 2018 Jul 25.
6
Strengths and weaknesses of renal markers as risk factors and surrogate markers.肾标志物作为风险因素和替代标志物的优势和劣势。
Kidney Int. 2011 Jun;79(12):1272-4. doi: 10.1038/ki.2011.61.
7
Uric acid and mild renal impairment in patients with ST-elevation myocardial infarction.ST段抬高型心肌梗死患者的尿酸与轻度肾功能损害
Scand Cardiovasc J. 2015 Feb;49(1):14-9. doi: 10.3109/14017431.2015.1005662. Epub 2015 Feb 12.
8
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.估算肾小球滤过率降低和白蛋白尿升高与全因和心血管死亡率相关。高危人群队列的协作荟萃分析。
Kidney Int. 2011 Jun;79(12):1341-52. doi: 10.1038/ki.2010.536. Epub 2011 Feb 9.
9
Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate.内源性肾功能标志物与结局的相关性：肾小球滤过率的多与少。
Curr Opin Nephrol Hypertens. 2013 May;22(3):331-5. doi: 10.1097/MNH.0b013e32835fe5ad.
10
The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.对比剂容积与肾小球滤过率的比值可预测 ST 段抬高型急性心肌梗死经皮冠状动脉介入治疗的结局。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.
引用本文的文献
1
The impact of household air pollution from solid fuel use on rapid decline in kidney function and chronic kidney disease: A nationwide longitudinal cohort study.使用固体燃料造成的家庭空气污染对肾功能快速下降和慢性肾病的影响：一项全国性纵向队列研究。
J Nutr Health Aging. 2025 Aug 1;29(10):100641. doi: 10.1016/j.jnha.2025.100641.
2
Questionable Validity of Creatinine-Based eGFR in Elderly Patients but Cystatin C Is Helpful in First-Line Diagnostics.基于肌酐的估算肾小球滤过率（eGFR）在老年患者中的有效性存疑，但胱抑素C有助于一线诊断。
Geriatrics (Basel). 2023 Dec 8;8(6):120. doi: 10.3390/geriatrics8060120.
3
Association between sleep duration and quality with rapid kidney function decline and development of chronic kidney diseases in adults with normal kidney function: The China health and retirement longitudinal study.睡眠时长和质量与肾功能快速下降及肾功能正常成年人慢性肾脏病发生的关系：中国健康与养老追踪调查。
Front Public Health. 2023 Jan 18;10:1072238. doi: 10.3389/fpubh.2022.1072238. eCollection 2022.
4
Cystatin C: A Primer for Pharmacists.胱抑素C：药剂师入门指南。
Pharmacy (Basel). 2020 Mar 9;8(1):35. doi: 10.3390/pharmacy8010035.
5
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.胱抑素C检测在慢性肾脏病诊断和管理中的临床效用及成本影响：一项初级保健队列研究
PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.
本文引用的文献
1
Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine.实测的肾小球滤过率并不能改善胱抑素C和肌酐对死亡率的预测。
Nephrol Dial Transplant. 2017 Apr 1;32(4):663-670. doi: 10.1093/ndt/gfx004.
2
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?临床实践和研究中用于测量肾小球滤过率的碘海醇血浆清除率：综述。第1部分：如何用碘海醇测量肾小球滤过率？
Clin Kidney J. 2016 Oct;9(5):682-99. doi: 10.1093/ckj/sfw070. Epub 2016 Aug 23.
3
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.慢性肾脏病中低分子量血清蛋白滤过标志物的非肾小球滤过率决定因素
Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.
4
The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes.蛋白酶抑制剂胱抑素 C 下调脂多糖激活的单核细胞中白细胞介素-β和肿瘤坏死因子-α的释放。
J Leukoc Biol. 2016 Oct;100(4):811-822. doi: 10.1189/jlb.5A0415-174R. Epub 2016 May 17.
5
Estimated Glomerular Filtration Rate: Fit for What Purpose?估计肾小球滤过率：适用于何种目的？
Nephron. 2016;134(1):43-9. doi: 10.1159/000444062. Epub 2016 Feb 5.
6
Past Decline Versus Current eGFR and Subsequent Mortality Risk.既往肾功能下降情况与当前估算肾小球滤过率及后续死亡风险的关系
J Am Soc Nephrol. 2016 Aug;27(8):2456-66. doi: 10.1681/ASN.2015060688. Epub 2015 Dec 11.
7
The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors.胱抑素C/肌酐比值，一种肾小球滤过质量的标志物：健康老年人的相关因素、参考区间以及发病和死亡预测
Transl Res. 2016 Mar;169:80-90.e1-2. doi: 10.1016/j.trsl.2015.11.001. Epub 2015 Nov 14.
8
Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.血清胱抑素 C 作为加重期和缓解期 COPD 患者的炎症标志物。
Inflammation. 2016 Apr;39(2):625-31. doi: 10.1007/s10753-015-0287-x.
9
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.估算肾小球滤过率和尿白蛋白排泄率对心血管结局的预测作用：个体参与者数据的协作荟萃分析。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28.
10
Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.肾小球孔径减小并不局限于孕妇。一种新综合征“缩小孔径综合征”的证据。
Scand J Clin Lab Invest. 2015 Jul;75(4):333-40. doi: 10.3109/00365513.2015.1025427.
Zotero 插件